Healthcare News
Once-daily oral treatment for obesity that mimics metabolic effects of gastric bypass shows promise in study
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive preliminary data for the safe and effective redirection of nutrient absorption into the lower intestine, the weight loss and metabolic management mechanism behind gastric bypass surgery.
Protein bars enriched with collagen have potential as a weight-loss aid, study finds
Research being presented at the European Congress on Obesity (ECO 2025) and published in the journal Nutrients indicates that collagen could be a safe and effective weight-loss supplement.
GLP-1 drugs are helpful for children who are living with severe obesity, research finds
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of a hormone called GLP-1 to reduce appetite and feelings of hunger, slow the release of food from the stomach and increase feelings of fullness after eating.
‘We have work to do’: No weight loss benefit with semaglutide before bariatric surgery
Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.
4:3 intermittent fasting produces greater weight loss vs. daily calorie restriction
Adults who fasted 3 nonconsecutive days a week lost more weight vs. those assigned to daily calorie restriction.